Steven Mayer Elected to the FNIH Board of Directors
Steven C. Mayer was unanimously elected to the Foundation for the National Institutes of Health (FNIH) Board of Directors. He began his term May 16, 2012.
Steven C. Mayer, Former CEO and Co-Founder of CoGenesys, Inc., Elected to the Foundation for the National Institutes of Health’s Board of Directors
BETHESDA, MD, July 9, 2012 — Steven C. Mayer was unanimously elected to the Foundation for the National Institutes of Health (FNIH) Board of Directors. He began his term May 16, 2012.
Prior to founding CoGenesys, Mayer was executive vice president and chief financial officer of Human Genome Sciences, Inc; vice president and chief financial officer of GenVec, Inc.; and senior vice president and chief financial officer of TheraTech, Inc.
“Steve’s experience as an entrepreneur in the biomedical field will bring a fresh perspective to the FNIH board,” according to Charles A. Sanders, MD, FNIH chairman. “He will be another excellent resource for us to tap into as we enter our 16th year in operation.”
“The FNIH board will benefit from Steve’s expertise in the pharmaceutical and healthcare industries,” says Paul M. Montrone, PhD, FNIH board treasurer. “He will especially add depth to the financial aspects of the FNIH mission.”
“I am very pleased to be joining the FNIH board and hope that my background in finance and biotechnology will enable me to help further the goals of the FNIH in its role of supporting the National Institutes of Health,” says Mayer.
Mayer has served on the NASDAQ Issuer Affairs Committee, on the FASB Small Business Advisory Committee as a director and treasurer of the Strathmore Hall Foundation, as well as a trustee of The Norwood School.
Among the board members’ responsibilities are helping guide the FNIH’s mission and purpose; ensuring effective organizational planning; ensuring adequate resources and managing them effectively; reviewing, monitoring, and strengthening FNIH’s programs and services; and enhancing FNIH’s public standing.
In total, eight people were elected to the FNIH Board of Directors this spring. They are: Mr. Jim Donovan; Paul Herrling, PhD; Ronald L. Krall, MD; Edison Liu, MD; Mr. Joel S. Marcus; Garry A. Neil, MD; and Mrs. Nina Solarz.
About the Foundation for the NIH
Established by the United States Congress to support the mission of the NIH — improving health through scientific discovery in the search for cure — the Foundation for the NIH is a leader in identifying and addressing complex scientific and health issues. The Foundation is a not-for-profit, 501(c)(3) charitable organization that raises private-sector funds for a broad portfolio of unique programs that complement and enhance the NIH priorities and activities. For additional information about the Foundation for the NIH, visit www.fnih.org.